Vaccine Regimens and the Future of Covid-19 Boosters: Heterologous and Homologous Strategies of Vaccination
DOI:
https://doi.org/10.58445/rars.206Keywords:
Vaccines, Covid-19, ImmunologyAbstract
The advent of mRNA vaccines against the SARS-CoV-2 virus, which caused the global Covid19 pandemic, has dramatically changed the future of vaccination in the U.S. and abroad. Although existing mRNA vaccines are safe and effective for preventing serious illness from Covid19, much is still unknown about the optimal vaccination strategy. As Covid19, much like influenza, is expected to become endemic in the human population, a yearly vaccine will likely become part of standard health care practices. This review begins with a brief overview of adaptive immunity and explores how different types of vaccines stimulate an immune response. The effectiveness of different vaccination regimens against various diseases and how heterologous vs. homologous vaccination strategies can differentially induce immune response are then discussed. Finally, we conclude by speculating on the future of Covid vaccination and mRNA vaccines in general.
References
Definition of adaptive immunity - NCI Dictionary of Cancer Terms - NCI. (n.d.). Retrieved March 14, 2023, from https://www.cancer.gov/publications/dictionaries/cancer-terms/def/adaptive-immunity
Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition. New York: Garland Science; 2002. Chapter 24, The Adaptive Immune System. Available from: https://www.ncbi.nlm.nih.gov/books/NBK21070/
Wilson, P., Andrews, S. Tools to therapeutically harness the human antibody response. Nat Rev Immunol 12, 709–719 (2012). https://doi.org/10.1038/nri3285
Understanding How COVID-19 Vaccines Work | CDC. (n.d.). Retrieved March 14, 2023, from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-they-work.html
Bischoff, W. E., Mcnall, R. J., Blevins, M. W., Turner, J. L., Lopareva, E. N., Rota, P. A., & Stehle, J. R. (2016). Detection of Measles Virus RNA in Air and Surface Specimens in a Hospital Setting. The Journal of Infectious Diseases, 213(4), 600–603. https://doi.org/10.1093/INFDIS/JIV465
Romero, J. R., & Modlin, J. F. (2015). Poliovirus. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 2, 2073-2079.e2. https://doi.org/10.1016/B978-1-4557-4801-3.00173-9
Matua GA, Van der Wal DM, Locsin RC. Ebolavirus and Haemorrhagic Syndrome. Sultan Qaboos Univ Med J. 2015 May;15(2):e171-6. Epub 2015 May 28. PMID: 26052448; PMCID: PMC4450778.
Vaccine Types | NIH: National Institute of Allergy and Infectious Diseases. (n.d.). Retrieved March 14, 2023, from https://www.niaid.nih.gov/research/vaccine-types
Vaccine Types | HHS.gov. (n.d.). Retrieved March 14, 2023, from https://www.hhs.gov/immunization/basics/types/index.html
Measles, Mumps, and Rubella (MMR) Vaccination | CDC. (n.d.). Retrieved March 14, 2023, from https://www.cdc.gov/vaccines/vpd/mmr/public/index.html
HPV Vaccine Administration | CDC. (n.d.). Retrieved March 14, 2023, from https://www.cdc.gov/vaccines/vpd/hpv/hcp/administration.html
Polio Vaccination: What Everyone Should Know | CDC. (n.d.). Retrieved March 14, 2023, from https://www.cdc.gov/vaccines/vpd/polio/public/index.html
Ebola virus disease: Vaccines. (n.d.). Retrieved March 14, 2023, from https://www.who.int/news-room/questions-and-answers/item/ebola-vaccines
Jain S, Venkataraman A, Wechsler ME, Peppas NA. Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic. Adv Drug Deliv Rev. 2021 Oct 9;179:114000. doi: 10.1016/j.addr.2021.114000. Epub ahead of print. PMID: 34637846; PMCID: PMC8502079.
What are protein subunit vaccines and how could they be used against COVID-19? | Gavi, the Vaccine Alliance. (n.d.). Retrieved March 14, 2023, from https://www.gavi.org/vaccineswork/what-are-protein-subunit-vaccines-and-how-could-they-be-used-against-covid-19
Understanding How COVID-19 Vaccines Work | CDC. (n.d.). Retrieved March 14, 2023, from https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/how-they-work.html
Jain, S., Venkataraman, A., Wechsler, M. E., & Peppas, N. A. (2021). Messenger RNA-based vaccines: Past, present, and future directions in the context of the COVID-19 pandemic. Advanced Drug Delivery Reviews, 179, 114000. https://doi.org/10.1016/J.ADDR.2021.114000
Verbeke, R., Lentacker, I., de Smedt, S. C., & Dewitte, H. (2021). The dawn of mRNA vaccines: The COVID-19 case. Journal of Controlled Release, 333, 511. https://doi.org/10.1016/J.JCONREL.2021.03.043
Heidary, M., Kaviar, V. H., Shirani, M., Ghanavati, R., Motahar, M., Sholeh, M., Ghahramanpour, H., & Khoshnood, S. (2022). A Comprehensive Review of the Protein Subunit Vaccines Against COVID-19. Frontiers in Microbiology, 13. https://doi.org/10.3389/FMICB.2022.927306
Claes, K. J., Geerts, I., Lemahieu, W., Wilmer, A., Kuypers, D. R. J., Koshy, P., & Ombelet, S. (2023). Atypical Hemolytic Uremic Syndrome Occurring After Receipt of mRNA-1273 COVID-19 Vaccine Booster: A Case Report. American Journal of Kidney Diseases, 81(3), 364–367. https://doi.org/10.1053/J.AJKD.2022.07.012
Costa Clemens SA, Weckx L, Clemens R, Almeida Mendes AV, Ramos Souza A, Silveira MBV, da Guarda SNF, de Nobrega MM, de Moraes Pinto MI, Gonzalez IGS, Salvador N, Franco MM, de Avila Mendonça RN, Queiroz Oliveira IS, de Freitas Souza BS, Fraga M, Aley P, Bibi S, Cantrell L, Dejnirattisai W, Liu X, Mongkolsapaya J, Supasa P, Screaton GR, Lambe T, Voysey M, Pollard AJ; RHH-001 study team. Heterologous versus homologous COVID-19 booster vaccination in previous recipients of two doses of CoronaVac COVID-19 vaccine in Brazil (RHH-001): a phase 4, non-inferiority, single blind, randomised study. Lancet. 2022 Feb 5;399(10324):521-529. doi: 10.1016/S0140-6736(22)00094-0. Epub 2022 Jan 21. PMID: 35074136; PMCID: PMC8782575.
Ringe R, Bhattacharya J. Preventive and therapeutic applications of neutralizing antibodies to Human Immunodeficiency Virus Type 1 (HIV-1). Ther Adv Vaccines. 2013 Jul;1(2):67-80. doi: 10.1177/2051013613494534. PMID: 24757516; PMCID: PMC3967664.
Atmar, R. L., Lyke, K. E., Deming, M. E., Jackson, L. A., Branche, A. R., el Sahly, H. M., Rostad, C. A., Martin, J. M., Johnston, C., Rupp, R. E., Mulligan, M. J., Brady, R. C., Frenck, R. W., Bäcker, M., Kottkamp, A. C., Babu, T. M., Rajakumar, K., Edupuganti, S., Dobrzynski, D., … Beigel, J. H. (2022). Homologous and Heterologous Covid-19 Booster Vaccinations. New England Journal of Medicine, 386(11), 1046–1057. https://doi.org/10.1056/NEJMOA2116414/SUPPL_FILE/NEJMOA2116414_DATA-SHARING.PDF
Hervé, C., Laupèze, B., Del Giudice, G. et al. The how’s and what’s of vaccine reactogenicity. npj Vaccines 4, 39 (2019). https://doi.org/10.1038/s41541-019-0132-6
Au W Y, Cheung P P. Effectiveness of heterologous and homologous covid-19 vaccine regimens: living systematic review with network meta-analysis BMJ 2022; 377 :e069989 doi:10.1136/bmj-2022-069989
Vaccine Dosing & Schedule. (n.d.). Retrieved April 20, 2023, from https://www.idsociety.org/covid-19-real-time-learning-network/vaccines/vaccine-dosing--schedule/
Lin, D.-Y., Xu, Y., Gu, Y., Zeng, D., Wheeler, B., Young, H., Sunny, S. K., & Moore, Z. (2023). Effectiveness of Bivalent Boosters against Severe Omicron Infection. New England Journal of Medicine, 388(8), 764–766. https://doi.org/10.1056/NEJMC2215471
Deng, J.; Ma, Y.; Liu, Q.; Du, M.; Liu, M.; Liu, J. Comparison of the Effectiveness and Safety of Heterologous Booster Doses with Homologous Booster Doses for SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis. Int. J. Environ. Res. Public Health 2022, 19, 10752. https://doi.org/10.3390/ijerph191710752
Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 4th edition. New York: Garland Science; 2002. Protein Function. Available from: https://www.ncbi.nlm.nih.gov/books/NBK26911/
Cohen FS. How Viruses Invade Cells. Biophys J. 2016 Mar 8;110(5):1028-32. doi: 10.1016/j.bpj.2016.02.006. PMID: 26958878; PMCID: PMC4788752.
Clinical Guidance for COVID-19 Vaccination | CDC. (n.d.). Retrieved April 20, 2023, from https://www.cdc.gov/vaccines/covid-19/clinical-considerations/interim-considerations-us.html
CDC Seasonal Flu Vaccine Effectiveness Studies | CDC. (n.d.). Retrieved April 20, 2023, from https://www.cdc.gov/flu/vaccines-work/effectiveness-studies.htm
Grohskopf, L. A., Blanton, L. H., Ferdinands, J. M., Chung, J. R., Broder, K. R., Talbot, H. K., Morgan, R. L., & Fry, A. M. (2022). Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022–23 Influenza Season. MMWR Recommendations and Reports, 71(1). https://doi.org/10.15585/MMWR.RR7101A1
Falcaro, M., Castañon, A., Ndlela, B., Checchi, M., Soldan, K., Lopez-Bernal, J., Elliss-Brookes, L., & Sasieni, P. (2021). The effects of the national HPV vaccination programme in England, UK, on cervical cancer and grade 3 cervical intraepithelial neoplasia incidence: a register-based observational study. The Lancet, 398(10316), 2084–2092. https://doi.org/10.1016/S0140-6736(21)02178-4
Comirnaty® (COVID-19 Vaccine, mRNA) | Official Site. (n.d.). Retrieved April 20, 2023, from https://www.covidvaxoption.com/
What COVID-19 vaccine side effects do and don’t mean | Nebraska Medicine Omaha, NE. (n.d.). Retrieved April 20, 2023, from https://www.nebraskamed.com/COVID/what-covid-19-vaccine-side-effects-do-and-dont-mean
Menni, C., May, A., Polidori, L., Louca, P., Wolf, J., Capdevila, J., Hu, C., Ourselin, S., Steves, C. J., Valdes, A. M., & Spector, T. D. (2022). COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study. The Lancet Infectious Diseases, 22(7), 1002–1010. https://doi.org/10.1016/S1473-3099(22)00146-3
Future COVID-19 booster shots will likely need fresh formulations as new coronavirus variants of concern continue to emerge | Gavi, the Vaccine Alliance. (n.d.). Retrieved April 20, 2023, from https://www.gavi.org/vaccineswork/future-covid-19-booster-shots-will-likely-need-fresh-formulations-new-coronavirus
Thompson, M. G., Pierse, N., Sue Huang, Q., Prasad, N., Duque, J., Claire Newbern, E., Baker, M. G., Turner, N., & McArthur, C. (2018). Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015. Vaccine, 36(39), 5916–5925. https://doi.org/10.1016/J.VACCINE.2018.07.028
BioRender: Learning Hub. Scientific Image and Illustration Software. (n.d.). Retrieved May 15 2023, from www.biorender.com/learn
Johnson and Johnson vaccine How is it different | VCU Health. (n.d.). Retrieved May 9, 2023, from https://www.vcuhealth.org/news/covid-19/johnson-and-johnson-vaccine-how-is-it-different
Definition of seropositive - NCI Dictionary of Cancer Terms - NCI. (n.d.). Retrieved May 9, 2023, from https://www.cancer.gov/publications/dictionaries/cancer-terms/def/seropositive
Downloads
Posted
Categories
License
Copyright (c) 2023 Diya Sammanna
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.